Adrenergic and dopaminergic modulation of immunity in multiple sclerosis: teaching old drugs new tricks? (Q38052870)

27 August 2017

title

Adrenergic and dopaminergic modulation of immunity in multiple sclerosis: teaching old drugs new tricks? (English)

1 reference

27 August 2017

0 references

1 reference

Marco Cosentino

0 references

Franca Marino

1 reference

27 August 2017

publication date

17 October 2012

1 reference

Journal of Neuroimmune Pharmacology

27 August 2017

published in

1 reference

27 August 2017

1 reference

27 August 2017

1 reference

27 August 2017

page(s)

163-179

1 reference

Dopamine, a neurotransmitter, influences the immune system

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

The physiology, signaling, and pharmacology of dopamine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Dopamine, as well as norepinephrine, is a link between noradrenergic nerve terminals and splenocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

In vitro effects of cocaine, lidocaine and monoamine uptake inhibitors on lymphocyte proliferative responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Dopamine by itself activates either D2, D3 or D1/D5 dopaminergic receptors in normal human T-cells and triggers the selective secretion of either IL-10, TNFalpha or both.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Interactions between the sympathetic nervous system and the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Catecholamine production and tyrosine hydroxylase expression in peripheral blood mononuclear cells from multiple sclerosis patients: effect of cell stimulation and possible relevance for activation-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Stimulation with phytohaemagglutinin induces the synthesis of catecholamines in human peripheral blood mononuclear cells: role of protein kinase C and contribution of intracellular calcium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Unravelling dopamine (and catecholamine) physiopharmacology in lymphocytes: open questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Interferon-gamma and interferon-beta affect endogenous catecholamines in human peripheral blood mononuclear cells: implications for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Human CD4+CD25+ regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine/paracrine inhibitory functional loop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Antipsychotic treatment of psychosis associated with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Use of Ephedra-containing products and risk for hemorrhagic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Astrocytic beta2-adrenergic receptors and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Hypoperfusion of the cerebral white matter in multiple sclerosis: possible mechanisms and pathophysiological significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Astrocytes as potential targets to suppress inflammatory demyelinating lesions in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Monoamine neurotoxins-induced apoptosis in lymphocytes by a common oxidative stress mechanism: involvement of hydrogen peroxide (H(2)O(2)), caspase-3, and nuclear factor kappa-B (NF-kappaB), p53, c-Jun transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Dopaminergic D1-like receptor-dependent inhibition of tyrosine hydroxylase mRNA expression and catecholamine production in human lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

The two faces of L-DOPA: benefits and adverse side effects in the treatment of Encephalitis lethargica, Parkinson's disease, multiple sclerosis and amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Multiple sclerosis--the plaque and its pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Association between the gamma-aminobutyric acid A3 receptor gene and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Post-receptorial mechanisms underlie functional disregulation of beta2-adrenergic receptors in lymphocytes from Multiple Sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Dopamine fails to regulate activation of peripheral blood lymphocytes from multiple sclerosis patients: effects of IFN-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

α1-Adrenergic Receptors Positively Regulate Toll-Like Receptor Cytokine Production from Human Monocytes and Macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Autonomic dysfunction in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

What do we know about the mechanism of action of disease-modifying treatments in MS?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Immunopathogenesis and immunotherapy of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Possible use of amantadine in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Therapeutic role of beta-interferons in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Increased high affinity beta-adrenergic receptor densities and cyclic AMP responses of CD8 cells in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Multiple sclerosis immunology: The healthy immune system vs the MS immune system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

A randomized controlled double-masked trial of albuterol add-on therapy in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

The mechanism of action of interferon-β in relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Hyperprolactinemia in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Lymphocyte norepinephrine and epinephrine, but not plasma catecholamines predict lymphocyte cAMP production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

The changing demographic pattern of multiple sclerosis epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

The safety and efficacy of IFN-beta products for the treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

The CD4-Th1 model for multiple sclerosis: a critical [correction of crucial] re-appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Dopamine interacts directly with its D3 and D2 receptors on normal human T cells, and activates beta1 integrin function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Potential of beta2-adrenoceptor agonists as add-on therapy for multiple sclerosis: focus on salbutamol (albuterol).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Alterations of the dopamine transporter in resting lymphocytes of patients with different psychotic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Interferon-beta: mechanism of action and dosing issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Upregulation of lymphocyte apoptosis as a strategy for preventing and treating autoimmune disorders: a role for whole-food vegan diets, fish oil and dopamine agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Multiple sclerosis and the autonomic nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Treatment of relapsing-remitting multiple sclerosis: current approaches and unmet needs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Human FoxP3+CD4+ regulatory T cells: their knowns and unknowns

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Vesicular storage of 3,4-dihydroxyphenylethylamine and noradrenaline in terminal sympathetic nerves of dog spleen and kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Catecholamine content and in vitro catecholamine synthesis in peripheral human lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Antagonizing dopamine D1-like receptor inhibits Th17 cell differentiation: preventive and therapeutic effects on experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Dopamine Induces IL-6–Dependent IL-17 Production via D1-Like Receptor on CD4 Naive T Cells and D1-Like Receptor Antagonist SCH-23390 Inhibits Cartilage Destruction in a Human Rheumatoid Arthritis/SCID Mouse Chimera Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Autonomic innervation and regulation of the immune system (1987-2007)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Immunomodulation in multiple sclerosis: from immunosuppression to neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Hyperprolactinemia and autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Role of dopamine in the physiology of T-cells and dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Catecholamine levels in peripheral blood lymphocytes from multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Ultrastructural localization of tyrosine hydroxylase in human peripheral blood mononuclear cells: effect of stimulation with phytohaemagglutinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

The role of prolactin in autoimmune demyelination: Suppression of experimental allergic encephalomyelitis by bromocriptine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Beta-interferon for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Circulating dopamine level, in lung carcinoma patients, inhibits proliferation and cytotoxicity of CD4+ and CD8+ T cells by D1 dopamine receptors: an in vitro analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

FOXP3+ regulatory T cells in the human immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

The immunoregulatory role of dopamine: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Increasing CNS noradrenaline reduces EAE severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

IFN-gamma production by Th1 cells generated from naive CD4+ T cells exposed to norepinephrine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Disturbed regulatory T cell homeostasis in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

The interplay between the immune and central nervous systems in neuronal injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Therapy with interferon-beta modulates endogenous catecholamines in lymphocytes of patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

beta-Adrenergic receptor density and function of peripheral blood mononuclear cells are increased in multiple sclerosis: a regulatory role for cortisol and interleukin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Increased expression of high affinity IL-2 receptors and beta-adrenoceptors on peripheral blood mononuclear cells is associated with clinical and MRI activity in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Expression of beta2 adrenoreceptors on peripheral blood mononuclear cells in patients with primary and secondary progressive multiple sclerosis: a longitudinal six month study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

The role of regulatory T cells in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Phagocyte-derived catecholamines enhance acute inflammatory injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-012-9410-Z

Therapeutic effect of the D2-dopamine agonist bromocriptine on acute and relapsing experimental allergic encephalomyelitis

21 January 2018

1 reference

12 December 2020

Are astrocytes central players in the pathophysiology of multiple sclerosis?

1 reference

12 December 2020

Amantadine for fatigue in multiple sclerosis

1 reference

12 December 2020

HPLC-ED measurement of endogenous catecholamines in human immune cells and hematopoietic cell lines

1 reference

12 December 2020

Sympathetic skin responses are decreased and lymphocyte beta-adrenergic receptors are increased in progressive multiple sclerosis

1 reference

12 December 2020

Dopamine, serotonin and noradrenaline changes in the striatum of C57BL mice following myelin oligodendrocyte glycoprotein (MOG) 35-55 and complete Freund adjuvant (CFA) administration.

1 reference

12 December 2020

Bromocriptine therapy in multiple sclerosis: an open label pilot study.

1 reference

12 December 2020

Central catecholamine neurotoxin administration. 1. Immunological changes associated with the suppression of experimental autoimmune encephalomyelitis

1 reference

12 December 2020

The beta-adrenergic agonist isoproterenol suppresses experimental allergic encephalomyelitis in Lewis rats

1 reference

12 December 2020

Platelet monoamine oxidase and plasma dopamine-beta-hydroxylase activities in patients with multiple sclerosis

1 reference

12 December 2020

Dopaminergic Modulation of CD4+CD25high Regulatory T Lymphocytes in Multiple Sclerosis Patients during Interferon-ß Therapy

1 reference

12 December 2020

The beta 2-adrenergic agonist terbutaline suppresses experimental allergic neuritis in Lewis rats

1 reference

12 December 2020

1 reference

12 December 2020

Plasma neurotransmitters and cortisol in chronic illness: role of stress

1 reference

12 December 2020

Identification of catecholamines in the immune system by electrospray ionization mass spectrometry

1 reference

12 December 2020

Suppression of clinical weakness in experimental autoimmune encephalomyelitis associated with weight changes, and post-decapitation convulsions after intracisternal-ventricular administration of 6-hydroxydopamine

1 reference

12 December 2020

Endogenous catecholamine synthesis, metabolism, storage and uptake in human neutrophils

1 reference

12 December 2020

Endogenous catecholamine synthesis, metabolism storage, and uptake in human peripheral blood mononuclear cells

1 reference

12 December 2020

The sympathetic nerve--an integrative interface between two supersystems: the brain and the immune system

1 reference

12 December 2020

Characteristics of tricyclic antidepressant binding sites associated with murine lymphocytes from spleen

1 reference

12 December 2020

Astrocytes in multiple sclerosis lack beta-2 adrenergic receptors

1 reference

12 December 2020

Blood lymphocyte beta-adrenergic receptors in multiple sclerosis

1 reference

12 December 2020

1 reference

12 December 2020

Norepinephrine depletion in the spinal cord gray matter of rats with experimental allergic encephalomyelitis

1 reference

12 December 2020

Autonomic dysfunction in central nervous system disorders

1 reference

12 December 2020

[3H]dihydroalprenolol binding to beta adrenergic receptors in multiple sclerosis brain

1 reference

12 December 2020

Chemical sympathectomy augments the severity of experimental allergic encephalomyelitis

1 reference

12 December 2020

Genetically determined failure of activation-induced apoptosis of autoreactive T cells as a cause of multiple sclerosis

1 reference

12 December 2020

Altered splenic catecholamine concentrations during experimental allergic encephalomyelitis

1 reference

12 December 2020

Impaired apoptosis in mitogen-stimulated lymphocytes of patients with multiple sclerosis

1 reference

12 December 2020

Catecholamines-crafty weapons in the inflammatory arsenal of immune/inflammatory cells or opening pandora's box?

1 reference

12 December 2020

Increased lymphocyte beta-adrenergic receptor density in progressive multiple sclerosis is specific for the CD8+, CD28- suppressor cell

1 reference

12 December 2020

Beta-adrenergic agonists suppress chronic/relapsing experimental allergic encephalomyelitis (CREAE) in Lewis rats

1 reference

12 December 2020

Neuropeptide Y plasma levels and serum dopamine-beta-hydroxylase activity in MS patients with and without abnormal cardiovascular reflexes

1 reference

12 December 2020

MPTP-induced central dopamine depletion exacerbates experimental autoimmune encephalomyelitis (EAE) in C57BL mice

1 reference

12 December 2020

10.1007/S11481-012-9410-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1008577582

0 references

1 reference